We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Heal thyself

16 July 2006 By Robert Cyran

The UK orthopaedic company s shares trade at a discount to its overseas peers. They should arguably trade at a premium. It should sell off its wound business and focus on the attractive orthopaedics business. That would release value.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)